Iovance Biotherapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 4.69 USD | 5,64 USD | 1,76 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 8,8 USD | 5 | 3 | 4 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 446.502.396 | 23,95 | 6,43 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Iovance Biotherapeutics Inc
Mitarbeiter 975
Handelsplatz NASDAQ
Ticker Symbol IOVA
IPO Datum 2010-10-15
Adresse 825 Industrial Road, San Carlos, CA, United States, 94070
Webseite https://www.iovance.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Frederick G. Vogt Esq., J.D., Ph.D. | Interim CEO, President, General Counsel, Corporate Secretary & Director |
| 2 | Ms. Corleen M. Roche | Chief Financial Officer |
| 3 | Dr. Igor P. Bilinsky Ph.D. | Chief Operating Officer |
| 4 | Dr. Raj K. Puri M.D., Ph.D. | Chief Regulatory Officer |
| 5 | Mr. Daniel G. Kirby | Chief Commercial Officer |
| 6 | Ms. Sara Pellegrino | Senior Vice President of Investor Relations & Corporate Communications |
| 7 | Ms. Tracy Winton | Executive Vice President of Human Resources |
| 8 | Mr. Howard B. Johnson M.B.A. | Chief Business Officer |
| 9 | Mr. Kevin Smyth | Executive Vice President of Quality |
| 10 | Dr. Brian Gastman M.D. | Executive Vice President of Translational Medicine & Research |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Mhr Fund Management Llc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 9 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 10 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Invenomic Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 12 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 13 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 14 | Palo Alto Investors, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 16 | Jane Street Group LLC | 0,00% | 0,00 Mio. USD |
| 17 | Nuveen, LLC | 0,00% | 0,00 Mio. USD |
| 18 | HRT FINANCIAL LLC | 0,00% | 0,00 Mio. USD |
| 19 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 20 | Two Sigma Advisers, LLC | 0,00% | 0,00 Mio. USD |